Australasian neurologists review the ‘new era’ of MS treatment
August 9, 2015A recent collaboration between MS neurologists has brought together the latest information on treatments and best practice for MS care.read more
Research
Australian researchers develop new method for identifying lesions
July 28, 2015Researchers from the Royal Melbourne Hospital and the University of Melbourne this week published new findings that could change the way doctors identify MS lesions using brain scanning.read more
Electronic questionnaires improves reporting of continence issues
July 14, 2015Bladder or bowel symptoms commonly occur in MS. The symptoms, including incontinence from the bladder or bowel, can have a profound effect upon an individual’s quality of life and self-esteem.…read more
New Australian study investigates the effect of genetic change on immune cells
July 14, 2015There are now over 110 genetic changes that are known to increase an individual’s susceptibility to MS.read more
Self-monitoring therapy helps reduce fatigue and stress in MS
July 9, 2015Fatigue is a common problem for many people with MS, and some people with MS can also experience mental health issues such as anxiety and stress. Each of these issues…read more
Predicting risk of disability
June 24, 2015Two articles published recently by Australian and international investigators using the MSBase database provide insight into several factors that most strongly predict the risk of accumulating MS-related disability.read more
Placental stem cells reduce disease in a laboratory model of MS
June 24, 2015An Australian research team led by Professor Claude Bernard and Dr Natalie Payne, working with colleagues at the Australian Regenerative Medicine Institute at Monash University in Victoria, have been investigating…read more
Two new studies identify genetic changes linked to specific symptoms of MS
June 23, 2015Over the last few years, genetic studies that included thousands of people with MS from around the world have identified a large number of genetic changes that may increase a…read more
NZ Incidence Study
June 21, 2015Incidence studies are a well validated tool to better elucidate the cause and risk factors of a disease and plan effective preventive and management strategies. New Zealand (NZ) is ideally…read more
Case of PML
June 12, 2015The pharmaceutical sponsor of Gilenya (fingolimod), Novartis, has this week reported one case of Progressive Multifocal Leukoencephalopathy (PML) in an individual currently being treated with Gilenya in Europeread more
US researchers discover new structures linking the brain and the immune system
June 11, 2015Researchers from the University of Virginia in the USA recently discovered a new structure linking the central nervous system and the immune system that had previously been unreported in the…read more
A shorter treatment gap is better when switching from natalizumab (Tysabri) to fingolimod (Gilenya)
June 9, 2015A shorter treatment gap is better when switching from natalizumab (Tysabri) to fingolimod (Gilenya)read more